1. The development of risk-based regulation in financial services: just “modelling through”?;Black,2005
2. FDA Fosters Pharmacogenomics;Branca,2002
3. Reputation and Power: Organisational Image and Pharmaceutical Regulation at the FDA;Carpenter,2010
4. Whatever Happened to Critical Path?;Clinton;Pharmaceutical Executive,2006
5. Life as Surplus: Biotechnology and Capitalism in the Neoliberal Era;Cooper,2008